Hackerbrief: Cannabinoids Show Promise in Removing Alzheimer's Plaque-Forming Proteins from Brain Cells, Salk Institute Study Reveals
Preliminary laboratory research from the Salk Institute suggests that tetrahydrocannabinol (THC) and other cannabis compounds may help brain cells remove amyloid beta, a toxic protein associated with Alzheimer's disease. Conducted on human neurons in a lab setting, these exploratory studies indicate cannabinoids could provide insights into inflammation's role in Alzheimer's and potentially lead to new treatments. Salk Professor David Schubert highlighted that this study is believed to be the first to show cannabinoids affecting both inflammation and amyloid beta accumulation in nerve cells. The research observed that THC significantly reduced amyloid beta levels and inflammatory responses in engineered nerve cells, improving cell survival. This mechanism involves brain cell receptors activated by both natural endocannabinoids and THC.
